Showing 121-130 of 8869 results for "".
Rosacea: Choosing Among the Topical and Systemic Therapeutic Options
https://practicaldermatology.com/topics/general-topics/rosacea-choosing-among-the-topical-and-systemic-therapeutic-options/21706/As the field of therapies available for rosacea has expanded, clinicians must weigh the topical and oral treatment options on a case-by-case basisAdvances in the Treatment of Reticular Erythematous Mucinosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/advances-in-the-treatment-of-reticular-erythematous-mucinosis/23491/Considering nicotinamide’s anti-inflammatory properties for inflammatory dermatological conditions to avoid steroid and antibiotic overuse.The Microbiome in Acne: Where are We Now?
https://practicaldermatology.com/topics/acne-rosacea/the-microbiome-in-acne-where-are-we-now/23731/As research reveals connections of the microbiome to skin disease, clinicians may discover new approaches to managing the disease.Study Highlights Top-Rated Dermatology Education Apps
https://practicaldermatology.com/topics/practice-management/study-highlights-top-rated-dermatology-education-apps/23565/Researchers rated apps based on four key features.Staphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/annual-trends-in-medicare-part-d-prescription-claims-for-guselkumab-20182020/28861/Jachin Wu, MD, FAAD, and colleagues talk about Medicare claims for guselkumabCollagen in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/collagen-atopic-dermatitis/27167/Kripa Ahuja, MS, and Peter Lio, MD, review a 2024 study from Szalsus et al. looking at the role of collagens in atopic dermatitis (AD).The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.Panic-induced Digital Marketing: Avoid Short-sighted Shifts in Long-term Strategy
https://practicaldermatology.com/topics/practice-management/panic-induced-digital-marketing-avoid-short-sighted-shifts-in-long-term-strategy/26662/Panic-induced Digital Marketing: Avoid Short-sighted Shifts in Long-term StrategyThe Future of Aesthetic Medicine in the US
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-future-of-aesthetic-medicine-in-the-us/23853/A look at five trends shaping the aesthetics market.